Physician

Hematology

Jonathan A. Polikoff, MD works in the field of Hematology. He studied medicine at Albany Medical College. He over the years received 3 awards: "Meaningful Use Stage 1 Certification", "Super Doctor" and "Top MD". Dr. Jonathan A. Polikoff is a published MD. He has 18 papers published. The most current publication "Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antib..."

Publications

---

• ATLAS: Randomized, Double-Blind, Placebo-Controlled, Phase IIIB Trial Comparing Bevacizumab Therapy With or Without Erlotinib, After Completion of Chemotherapy, With B...
• Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
• Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP ...
• Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.
• Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
• Organizational barriers to physician participation in cancer clinical trials.
• Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment o...
• Body weight correlates with mortality in early-stage breast cancer.
• Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antib...
• Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
• Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.
• Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.
• Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
• Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program.
• Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
• The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin Lymphoma of distinct histological origin.
• An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin''s Lymphoma.

Schools

---

• Albany Medical College

• Albany Memorial Hospital

• University Of California San Diego

Conditions Treated

---

• Acute Leukemia
• Anemia
• Deep Vein Thrombosis (DVT)
• Myelodysplastic Syndromes
• View All

Doctors Specialties

---

• Hematology

Accepted Insurances

---

Awards

---

• Meaningful Use Stage 1 Certification
• Super Doctor
• Top MD

Education

---

• Albany Medical Center
• Albany Medical College

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Achala B. Doraiswamy, MD This Doctor is OpenDoctor Recommended.
	Dr. Paul C. Cheng, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog